Professional Documents
Culture Documents
All banks/ DFIs are required to give summary discussion of the bank's/DFI's approach to assessing the adequacy o
The discussion of capital needs should be based on the following:
Identified objectives of the capital management, interalia, support the growth in shareholder value, protect c
Commitment to sound capital and debt ratio.
Overall capital needs.
An assessment of growth prospects.
Current and potential risk exposures across all the major risk types.
Sensitivity and stress analysis of growth and risk assumptions.
The ability of the bank/ DFI to raise capital in the domestic or offshore markets.
An assessment of economic capital requirements of the bank/ DFI as determined in terms of their internal ec
Scope Of Application
The banks /DFIs are required to describe the Scope of Application of Basel-III framework on the following lines:The name of the top banking entity to which the framework has been applied.
An outline of the differences in the basis of consolidations for accounting and regulatory purposes (e.g. equity met
following disclosures are also required to be made if bank/ DFI has subsidiaries/associates, overseas operations etc.
a)
b)
c)
d)
e)
f)
g)
The list of group entities (if any), which have been fully consolidated as per International Financial Reporti
The joint ventures (if any) which have been consolidated on prorata basis as per IFRS.
The list of group entities which are included under the regulatory scope of consolidation.
Explain the reasons for difference in the accounting and regulatory method of consolidation (if any).
The list of group entities (if any), which have not been considered for consolidation both under the accou
etc.
The aggregate amount of capital deficiencies in all subsidiaries which are not included in the regulatory sco
Any restrictions, or any major impediments, on transfer of funds or regulatory capital within the entities sub
Note 44.1
Page # 1
assessing the adequacy of the capital to support current and future business operations.
purposes (e.g. equity method, fair value etc.), with brief description of the entities. The
, overseas operations etc.
Note 44.1
Note 44.2
Rows #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
Note 44.2
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
Note 44.2
Note 44.2
Note 44.2
Page # 2
(Current Year)
(Prior Year)
Rupees in '000
Amount
Amount
Note 44.2
Note 44.2
Note 44.2.1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
Note 44.2.2
23
24
25
26
27
28
29
30
Note 44.2.3
31
32
33
34
35
36
* This column "Amounts subject to pre-Basel III treatment" has been added for reporting the amount of each regulator
treatment during the transitional period. The portion of the amount which has already been transitioned to the Basel III
Example: Conside
benefit pension fund net assets and in Dec 2014, a bank has PKR50 million of these assets. The transitional arrangements r
means that the bank will report PKR10 million in the first empty cell in Sr.# 5 and PKR40 mn in the second dotted cell (the
regulatory adjustment). The amount of dotted cells will be risk weighted and will be disclosed at Sr.# 37 (ii) as shown on ne
Note: Rows which are not applicable for any institution should be left blank
Note 44.2.4
37
(i)
(ii)
(iii)
(iv)
38
39
40
41
42
43
44
mn "Amounts subject to pre-Basel III treatment" has been added for reporting the amount of each regulatory deduction item that is
uring the transitional period. The portion of the amount which has already been transitioned to the Basel III rules would be reporte
Example: Consider that currently banks a
ion fund net assets and in Dec 2014, a bank has PKR50 million of these assets. The transitional arrangements require this bank to dedu
the bank will report PKR10 million in the first empty cell in Sr.# 5 and PKR40 mn in the second dotted cell (the total of the two cells the
adjustment). The amount of dotted cells will be risk weighted and will be disclosed at Sr.# 37 (ii) as shown on next page.
which are not applicable for any institution should be left blank
Additional Information
Risk Weighted Assets subject to pre-Basel III treatment
Risk weighted assets in respect of deduction items (which during the transitional period will be risk weighted subject to
Pre-Basel III Treatment)
of which: deferred tax assets
of which: Defined-benefit pension fund net assets
of which: Recognized portion of investment in capital of banking, financial and insurance entities where holding is
less than 10% of the issued common share capital of the entity
of which: Recognized portion of investment in capital of banking, financial and insurance entities where holding is
more than 10% of the issued common share capital of the entity
Amounts below the thresholds for deduction (before risk weighting)
Non-significant investments in the capital of other financial entities
Significant investments in the common stock of financial entities
Deferred tax assets arising from temporary differences (net of related tax liability)
Applicable caps on the inclusion of provisions in Tier 2
Provisions eligible for inclusion in Tier 2 in respect of exposures subject to standardized approach (prior to application of
cap)
Cap on inclusion of provisions in Tier 2 under standardized approach
Provisions eligible for inclusion in Tier 2 in respect of exposures subject to internal ratings-based approach (prior to
application of cap)
Cap for inclusion of provisions in Tier 2 under internal ratings-based approach
Note: Rows which are not applicable for any institution should be left blank
(Current Year)
Rupees in '000
Amount
Amounts subject
to Pre- Basel III
treatment*
Page # 3
(Prior Year)
Page # 4
(Current Year)
(Prior Year)
Rupees in '000
Amount
Amount
NOTE 44.3
All banks/ DFIs are required to follow a 3 step approach to ensure that the Basel III requirement to provide
regulatory capital elements back to the published financial statements is done in a consistent manner. Under
to show the link between their published balance sheet and the figures reported for the calculation of regulat
Step 1: Under Step 1, banks are required to use their balance sheet of the published financial statements based on t
(numbers reported in the 2nd column below) as a starting point and report the numbers for each item in the publish
regulatory scope of consolidation (3rd column below). If there are rows in the regulatory consolidation balance she
published financial statements, banks are required to add these and give a value of zero in the 2nd column. In case
identical to the scope of regulatory consolidation then banks are not required to undertake Step-1. Instead, t
and move to Step-2.
Table: 44.3.1
(in thousand PKR)
Assets
(1)
Cash and balances with treasury banks
Balanced with other banks
Lending to financial institutions
Investments
Advances
Operating fixed assets
Deferred tax assets
Other assets
Total assets
Liabilities & Equity
Bills payable
Borrowings
Deposits and other accounts
Sub-ordinated loans
Liabilities against assets subject to finance lease
Deferred tax liabilities
Other liabilities
Total liabilities
Share capital/ Head office capital account
Reserves
Unappropriated/ Unremitted profit/ (losses)
Minority Interest
Surplus on revaluation of assets
Total liabilities & equity
Note 44.3
Step 2: Under Step 2 banks are required to expand the balance sheet under the regulatory scope of consolidation (re
the capital adequacy disclosure template set out in Note 44.2. Each element must be given a reference number/le
Step-3. Given below are some examples of elements (in italic font) that may need to be expanded. However, the mo
would need to be disclosed.
Table: 44.3.2
Assets
(1)
Cash and balances with treasury banks
Balanced with other banks
Lending to financial institutions
Investments
of which: Non-significant investments in the capital instruments of banking,
financial and insurance entities exceeding 10% threshold
of which: significant investments in the capital instruments issued by banking,
financial and insurance entities exceeding regulatory threshold
of which: Mutual Funds exceeding regulatory threshold
of which: reciprocal crossholding of capital instrument (separate for CET1,
AT1, T2)
of which: others (mention details)
Advances
shortfall in provisions/ excess of total EL amount over eligible provisions
under IRB
general provisions reflected in Tier 2 capital
Fixed Assets
Deferred Tax Assets
of which: DTAs that rely on future profitability excluding those arising from
temporary differences
of which: DTAs arising from temporary differences exceeding regulatory
threshold
Other assets
of which: Goodwill
of which: Intangibles
of which: Defined-benefit pension fund net assets
Total assets
Liabilities & Equity
Bills payable
Borrowings
Deposits and other accounts
Sub-ordinated loans
of which: eligible for inclusion in AT1
of which: eligible for inclusion in Tier 2
Note 44.3
Other liabilities
Total liabilities
Share capital
of which: amount eligible for CET1
of which: amount eligible for AT1
Reserves
of which: portion eligible for inclusion in CET1(provide breakup)
of which: portion eligible for inclusion in Tier 2
Note 44.3
Step 3: Under Step 3, a column is added to the capital adequacy disclosure template given at Note 44.2 (including s
figures of this column with the expanded balance sheet of Step-2. For example, the template includes the line "good
"(j) - (o)" to show that row 9 of the template has been calculated as the difference between component "(j)" and com
in step 2. Since the following table 44.3.3 is repetition of Note 44.2 with the addition of the last column, theref
two options; (1) Use the table 44.3.3 as proposed below, or (2) just add the last column of table 44.3.3 to Note
Basel III Disclosure Template (with added column)
Table: 44.3.3
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
Note 44.3
22
25
26
27
23
24
28
29
30
31
Note 44.3
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
Tier 2 Capital
Qualifying Tier 2 capital instruments under Basel III plus any related share
premium
Capital instruments subject to phase out arrangement from tier 2 (Pre-Basel
III instruments)
Tier 2 capital instruments issued to third party by consolidated subsidiaries
(amount allowed in group tier 2)
of which: instruments issued by subsidiaries subject to phase out
General Provisions or general reserves for loan losses-up to maximum of
1.25% of Credit Risk Weighted Assets
Revaluation Reserves
of which: Revaluation reserves on fixed assets
Note 44.3
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
Note 44.3
Page # 5
nsure that the Basel III requirement to provide a full reconciliation of all
tatements is done in a consistent manner. Under this process all banks/ DFIs need
he figures reported for the calculation of regulatory capital.
eet of the published financial statements based on the accounting scope of consolidation
and report the numbers for each item in the published financial statements based on
re rows in the regulatory consolidation balance sheet that are not present in the
nd give a value of zero in the 2nd column. In case the accounting consolidation is
are not required to undertake Step-1. Instead, the bank should disclose this fact
As at period end
(2)
As at period end
(3)
Note 44.3
Page # 6
heet under the regulatory scope of consolidation (revealed in Step 1) to identify all the elements that are used in
Each element must be given a reference number/letter in the 4th column that will be used as a cross reference in
nt) that may need to be expanded. However, the more complex the balance sheet of the bank, the more items
As at period end
(2)
As at period end
(3)
Reference
(4)
a
b
c
d
e
f
g
h
i
j
k
l
m
n
Note 44.3
o
p
q
r
s
t
u
v
w
x
y
z
aa
ab
Note 44.3
Page # 7
disclosure template given at Note 44.2 (including sub-notes 44.2.1 to 44.2.3) and banks will cross reference
2. For example, the template includes the line "goodwill net of related deferred tax liability". The bank will put
as the difference between component "(j)" and component "(o)" of the regulatory scope balance sheet, illustrated
44.2 with the addition of the last column, therefore to reduce duplication, the bank may adopt any of the
) just add the last column of table 44.3.3 to Note 44.2 (including sub-notes 44.2.1 to 44.2.3).
(s)
(u)
(w)
(x)
(j) - (o)
(k) - (p)
(f)
{(h) - (r} * x%
{(l) - (q)} * x%
(d)
(ab)
Note 44.3
(i)
Note 44.3
Page # 8
(t)
(m)
(y)
(ac)
(ad)
(n)
(z)
(g)
portion of (aa)
Note 44.3
portion of (aa)
(v)
(ae)
(af)
Note 44.3
Note 44.4
Set out below is the template that banks must use to ensure that the key features of all regulatory capital instruments are di
NA if the question is not applicable). Banks are required to report each regulatory capital instrument in a separate colum
regulatory capital instruments of the bank/ banking group.
1
2
Issuer
Unique identifier (eg KSE Symbol or Bloomberg identifier etc.)
Instrument type
9
10
11
12
Note 44.4
13
14
15
16
17
18
19
Coupons / dividends
Fixed or floating dividend/ coupon
coupon rate and any related index/ benchmark
Existence of a dividend stopper
20
21
22
Noncumulative or cumulative
23
24
Convertible or non-convertible
Note 44.4
25
26
27
28
29
30
Write-down feature
31
32
33
34
35
36
37
Note 44.4
apital Instruments
ulatory capital instruments are disclosed. Banks will be required to complete all of the cells for each outstanding regulatory capital instrume
al instrument in a separate column of the template, such that the completed template would provide a "main features report" that summaries
Instrument - 2
Inst.- 3 & so
on
Note 44.4
Note 44.4
Note 44.4
Page # 9
red to complete all of the cells for each outstanding regulatory capital instrument (please insert
he completed template would provide a "main features report" that summaries all of the
ital instruments
Explanation
Specifies the regulatory capital treatment during Basel III transitional phase (i.e. the
component of capital that the instrument is being phased-out from).
Enter: [Common Equity Tier 1] [Additional Tier
1] [Tier 2]
Specifies regulatory capital treatment under Basel III rules not taking into account
transitional treatment.
Enter: [Common Equity Tier 1]
[Additional Tier 1] [Tier 2] [Ineligible]
Specifies the level(s) within the group at which the instrument is included in capital.
Enter: [Solo] [Group] [Solo and Group]
Enter: [Ordinary shares] [Perpetual non-cumulative preference shares] [perpetual
debt instruments] [Other Tier 2] (others: please specify)
Specifies amount recognized in regulatory capital.
Par value of instrument
Specifies accounting classification. Helps to assess loss absorbency.
Enter: [Shareholders' equity] [Liability - amortized cost]
[Liability - fair value option] [Non-controlling interest in consolidated subsidiary]
Enter: [Perpetual/
Note 44.4
Note 44.4
Page # 10
Specifies whether the instrument will: (i) always convert fully, (ii) may convert fully
or partially; or (iii) will always convert partially
Enter: one of
the options
Specifies rate of conversion into the more loss absorbent instrument. Helps to assess
the degree of loss absorbency.
For convertible instruments, specifies whether conversion is mandatory or optional.
Helps to assess loss absorbency.
Enter: [Mandatory] [Optional]
[NA]
For convertible instruments, specifies instrument type convertible into. Helps to
assess loss absorbency.
Enter: [Common Equity Tier
1] [Additional Tier 1] [Tier 2]
If convertible, specify issuer of instrument into which it converts.
Specifies whether there is a write down feature. Helps to assess loss absorbency.
Enter: [Yes] [No]
Specifies the trigger at which write-down occurs, including point of non-viability.
Where one or more authorities have the ability to trigger write-down, the authorities
should be listed. For each of the authorities it should be state whether it is the terms
of the contract of the instrument that provide the legal basis for the authority to
trigger write-down (a contractual approach) or whether the legal basis is provided by
statutory means (a statutory approach)
For each write-down trigger separately, specifies whether the instrument will (i)
always be written-down fully, (ii) may be written down partially; or (iii) will always
be written down partially. Help assess the level of loss absorbency at write-down
For write down instrument, specifies whether write down is permanent or temporary.
Helps to assess loss absorbency.
Enter: [Permanent] [Temporary]
[NA]
For instrument that has a temporary write-down, description of write-up mechanism.
Specifies instrument to which it is most immediately subordinate. Helps to assess
loss absorbency on gone-concern basis.
Specifies whether there are non-compliant features.
Enter: [Yes] [No]
If there are non-compliant features, specify which ones. Helps to assess instrument
loss absorbency.
Note 44.4
The capital requirements for the banking group as per the major risk categories should be indicated in the man
Credit Risk
On-Balance sheet
Portfolios subject to standardized approach (Simple or Comprehensive)
e.g.
e.g.
Off-Balance sheet
Non-market related
e.g. Financial guarantees, acceptances, performance related commitments, trade related etc.
Market related
e.g. Foreign Exchange contracts/ derivatives etc.
Equity Exposure Risk in the Banking Book
TOTAL
Note 44.5
Note 44.5
Current Year
Required
Page # 11
Note 44.5
Current Year
Actual
Prior Year
Required
Actual
Note 44.5